NEWS
The company, financed by Asabys Partners and AdBio, is the latest start-up launched by researchers at the CRG
TANGO2 mutations initiate fatal metabolic crises. The gene’s role in lipid metabolism and energy production explains why.
Findings shed light on how cells secrete just the right amount of the two proteins crucial for human health
Findings can lead to new strategies to accelerate or manipulate the molecular mechanisms involved to target cancer
Cells use editing tools to skip or rearrange information stored in DNA. A 10-million-euro ERC Synergy Grant will explore how to control this process with molecular precision.
In crisis, the nucleus calls antioxidant enzymes to the rescue. This indicates metabolic activity, which would be a profound paradigm shift with implications for cancer research.
Di Croce lab's group will leverage their expertise to help study the most frequent type of cancer
Dr. Lehner is recognised for his exceptional contributions to the advancement of biomedical and health science
Dr. Lehner is one of 80 scientists - and only one based in Spain - to be recognised by the prestigous national scientific academy of the UK
A European Innovation Council-funded project aims to quantify a cancer cell’s plasticity